Patents by Inventor Karunakar Neelam

Karunakar Neelam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral transmucosal drug delivery system
    Patent number: 10821118
    Abstract: This invention relates to dosage forms for the delivery of drugs across the oral mucosa having improved transmucosal permeability. More specifically, the invention relates to an oral transmucosal dosage form comprising a primary vehicle comprising a crystallization inhibition agent (CIA) system and a drug, and a secondary vehicle. It also relates to methods of designing and making this dosage form, methods of administering this dosage form and methods of packaging the dosage forms.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: November 3, 2020
    Assignee: Abon Pharmaceuticals LLC
    Inventors: Salah U. Ahmed, Yanming Zu, Karunakar Neelam, Saad Muntazim, Tahseen A. Chowdhury, Shiying Tian
  • Oral Transmucosal Drug Delivery System
    Publication number: 20180015102
    Abstract: This invention relates to dosage forms for the delivery of drugs across the oral mucosa having improved transmucosal permeability. More specifically, the invention relates to an oral transmucosal dosage form comprising a primary vehicle comprising a crystallization inhibition agent (CIA) system and a drug, and a secondary vehicle. It also relates to methods of designing and making this dosage form, methods of administering this dosage form and methods of packaging the dosage forms.
    Type: Application
    Filed: September 25, 2017
    Publication date: January 18, 2018
    Applicant: ABON PHARMACEUTICALS, LLC
    Inventors: Salah U. AHMED, Yanming ZU, Karunakar NEELAM, Saad MUNTAZIM, Tahseen A. CHOWDHURY, Shiying TIAN
  • Oral transmucosal drug delivery system
    Patent number: 9795616
    Abstract: This invention relates to dosage forms for the delivery of drugs across the oral mucosa having improved transmucosal permeability. More specifically, the invention relates to an oral transmucosal dosage form comprising a primary vehicle comprising a crystallization inhibition agent (CIA) system and a drug, and a secondary vehicle. It also relates to methods of designing and making this dosage form, methods of administering this dosage form and methods of packaging the dosage forms.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 24, 2017
    Assignee: Abon Pharmaceuticals LLC
    Inventors: Salah U. Ahmed, Yanming Zu, Karunakar Neelam, Saad Muntazim, Tahseen A. Chowdhury, Shiying Tian
  • Oral Transmucosal Drug Delivery System
    Publication number: 20160235764
    Abstract: This invention relates to dosage forms for the delivery of drugs across the oral mucosa having improved transmucosal permeability. More specifically, the invention relates to an oral transmucosal dosage form comprising a primary vehicle comprising a crystallization inhibition agent (CIA) system and a drug, and a secondary vehicle. It also relates to methods of designing and making this dosage form, methods of administering this dosage form and methods of packaging the dosage forms.
    Type: Application
    Filed: April 29, 2016
    Publication date: August 18, 2016
    Applicant: ABON PHARMACEUTICALS, LLC
    Inventors: Salah U. AHMED, Yanming ZU, Karunakar NEELAM, Saad MUNTAZIM, Tahseen A. CHOWDHURY, Shiying TIAN
  • Oral transmucosal drug delivery system
    Patent number: 9352047
    Abstract: This invention relates to dosage forms for the delivery of drugs across the oral mucosa having improved transmucosal permeability. More specifically, the invention relates to an oral transmucosal dosage form comprising a primary vehicle comprising a crystallization inhibition agent (CIA) system and a drug, and a secondary vehicle. It also relates to methods of designing and making this dosage form, methods of administering this dosage form and methods of packaging the dosage forms.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: May 31, 2016
    Assignee: ABON PHARMACEUTICALS, LLC
    Inventors: Salah U. Ahmed, Yanming Zu, Karunakar Neelam, Saad Muntazim, Tahseen A. Chowdhury, Shiying Tian
  • ORAL TRANSMUCOSAL DRUG DELIVERY SYSTEM
    Publication number: 20140142076
    Abstract: This invention relates to dosage forms for the delivery of drugs across the oral mucosa having improved transmucosal permeability. More specifically, the invention relates to an oral transmucosal dosage form comprising a primary vehicle comprising a crystallization inhibition agent (CIA) system and a drug, and a secondary vehicle. It also relates to methods of designing and making this dosage form, methods of administering this dosage form and methods of packaging the dosage forms.
    Type: Application
    Filed: November 14, 2013
    Publication date: May 22, 2014
    Applicant: ABON PHARMACEUTICALS, LLC
    Inventors: Salah U. AHMED, Yanming ZU, Karunakar NEELAM, Saad MUNTAZIM, Tahseen A. CHOWDHURY, Shiying TIAN
  • MODIFIED GASTRORETENTIVE DRUG DELIVERY SYSTEM FOR AMINE DRUGS
    Publication number: 20110287096
    Abstract: Oral dosage forms for basic amine drugs, the dosage forms having a gastro-retentive component and a non gastro-retentive component. These dosage forms are capable of providing both IR and SR release rates for these drugs. In addition, they provide for release of the drug in the stomach and/or intestine of a mammal to which such dosage forms are administered. Such dosage forms include tablets and capsules. Such dosage forms provide improved bioavailability of otherwise poorly bioavailable basic amine drugs.
    Type: Application
    Filed: May 18, 2011
    Publication date: November 24, 2011
    Applicant: ABON PHARMACEUTICALS, LLC
    Inventors: Sudhir GORUKANTI, Yanming Zu, Phanidhara Kotamraj, Karunakar Neelam, Salah U. Ahmed